Log In
BCIQ
Print this Print this
 

HiPEG IFN a-2a, biosimilar peginterferon alfa-2a

  Manage Alerts
Collapse Summary General Information
Company Abzena plc
DescriptionBiosimilar of peginterferon alfa-2a, a pegylated recombinant interferon (IFN) alfa-2a
Molecular Target Type I interferon (IFN) receptor 1
Mechanism of ActionType I interferon (IFN) receptor agonist; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today